Contact information
Colleges
Oliver Rider
BA (hons), BMBCh (hons), FRCP (UK), DPhil (Oxon)
Professor of Cardiovascular Medicine
- British Heart Foundation Senior Clinical Research Fellow
- Deputy Clinical Director of OCMR
- Honorary Consultant Cardiologist
After studying medicine at Pembroke College (1996-2002) I completed the Royal College Examinations and specialized in Cardiology. In 2005 I was awarded a Wellcome Trust Junior Research Fellowship to complete my DPhil in Cardiovascular medicine at Oxford, where I used advanced cardiac magnetic resonance imaging and spectroscopy to study the effects of obesity and weight loss on myocardial metabolism and function. For this work I was awarded the American Heart Association Young Investigator Award for Nutrition Physical Activity and Metabolism (2008) and took up the role of Clinical Lecturer in Cardiovascular Medicine in Oxford in 2010 where I furthered my research into obesity. In 2015 I was appointed as an Honorary Consultant Cardiologist and Deputy Clinical Director or the University of Oxford Centre for Clinical Magnetic Resonance Research. I held a British Heart Foundation Intermediate Clinical Research Fellowship between 2016 and 2022 and was awarded the BHF/BCS Michael Davies Early Career Award in 2019, and followed this with a British Heart Foundation Senior Clinical Research Fellowship award in 2022. I now run a research group that uses advanced cardiac magnetic resonance imaging and spectroscopy to investigate the relationship between cardiac substrate metabolism, cardiac energetics and cardiac function in multiple diseases with a focus on cardiometabolic heart disease and heart failure.
Recent publications
Protocol of the RADIO-STAR trial: a phase 1 safety and dose finding study of hypofractionated radiotherapy to the stellate ganglia for the treatment of ventricular arrhythmia.
Journal article
Bussmann BM. et al, (2026), BMJ Open, 16
HFpEF and MASLD: converging mechanisms and clinical implications.
Journal article
Capone F. et al, (2026), Nat Rev Cardiol
double-blind, randomized placebo-controlled trial examining the effect of MitoQ on myocardial energetics in patients with dilated cardiomyopathy.
Journal article
Halliday BP. et al, (2026), Eur Heart J Cardiovasc Imaging, 27, 74 - 77
Computational modelling of myocardial metabolism in patients with advanced heart failure.
Journal article
Beyhoff N. et al, (2025), Eur J Heart Fail, 27, 3411 - 3422
Evaluating early cardiology involvement and survival outcomes across NT-proBNP levels: An island-wide retrospective cohort study.
Journal article
Brown C. et al, (2025), Eur J Heart Fail, 27, 2935 - 2937